Rockefeller Financial Services’s Auspex Pharmaceuticals ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-5,346
Closed -$536K – 532
2015
Q1
$536K Buy
5,346
+641
+14% +$42.7K 0.01% 239
2014
Q4
$247K Buy
+4,705
New +$138K 0.01% 290

Rockefeller Financial Services's ASPX Position: Q2 2015 in Review

Rockefeller Financial Services sold out of Auspex Pharmaceuticals (ASPX) in Q2 2015, closing a stake of 5,346 shares — an estimated $536K sold.

Rockefeller Financial Services first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $536K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Rockefeller Financial Services reported no remaining Auspex Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Rockefeller Financial Services sold 5,346 Auspex Pharmaceuticals shares in Q2 2015, an estimated $536K.
  • Rockefeller Financial Services first reported a position in Auspex Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • Rockefeller Financial Services's Auspex Pharmaceuticals position peaked at $536K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Auspex Pharmaceuticals as of Q2 2015.

Based on Rockefeller Financial Services's 13F filing for Q2 2015, filed 14 Jul 2015.